Identification of microRNA-mRNA modules using microarray data by Jayaswal, Vivek et al.
METHODOLOGY ARTICLE Open Access
Identification of microRNA-mRNA modules using
microarray data
Vivek Jayaswal
1,2*, Mark Lutherborrow
3,4, David DF Ma
3,4, Yee H Yang
1,2
Abstract
Background: MicroRNAs (miRNAs) are post-transcriptional regulators of mRNA expression and are involved in
numerous cellular processes. Consequently, miRNAs are an important component of gene regulatory networks and
an improved understanding of miRNAs will further our knowledge of these networks. There is a many-to-many
relationship between miRNAs and mRNAs because a single miRNA targets multiple mRNAs and a single mRNA is
targeted by multiple miRNAs. However, most of the current methods for the identification of regulatory miRNAs
and their target mRNAs ignore this biological observation and focus on miRNA-mRNA pairs.
Results: We propose a two-step method for the identification of many-to-many relationships between miRNAs
and mRNAs. In the first step, we obtain miRNA and mRNA clusters using a combination of miRNA-target mRNA
prediction algorithms and microarray expression data. In the second step, we determine the associations between
miRNA clusters and mRNA clusters based on changes in miRNA and mRNA expression profiles. We consider the
miRNA-mRNA clusters with statistically significant associations to be potentially regulatory and, therefore, of
biological interest.
Conclusions: Our method reduces the interactions between several hundred miRNAs and several thousand
mRNAs to a few miRNA-mRNA groups, thereby facilitating a more meaningful biological analysis and a more
targeted experimental validation.
Background
MicroRNAs are short (20-22 nt) non-protein coding RNA
sequences that are involved in the post-transcriptional reg-
ulation of genes either by mRNA cleavage and degradation
or by repressing the translation of mRNA into proteins.
Though they are a relatively recent discovery, they are of
immense biological interest given their regulatory role in
numerous cellular processes, e.g. some miRNAs can act as
oncogenes or tumor-suppressors in humans [1-3].
The identification of regulatory miRNAs and their
target mRNAs is a major combinatorial challenge
because a single miRNA regulates multiple mRNAs
and several miRNAs co-regulate a single mRNA. The
many-to-many relationship between miRNAs and
mRNAs results in a powerful ability for miRNAs to
control cellular protein output and function. Therefore,
methods which are able to discover these miRNA-
based regulations may provide a means for identifying
the key cellular pathways that contribute to a biologi-
cal event, such as the initiation of cancer. One of the
widely used methods for the identification of regula-
tory miRNAs is based on mRNA microarray expression
data. Firstly, the putative miRNA-mRNA (miRmR)
pairs are identified using a prediction algorithm such
as TargetScanS [4], PicTar [5] or miRanda [6]. These
algorithms are based on miRNA and mRNA sequence
data and return thousands of putative miRmR pairs.
S e c o n d l y ,ag e n es e tt e s t( G S T )( e . g .[ 7 , 8 ] )i sp e r f o r m e d
to determine whether, for a given miRNA, the pre-
dicted target mRNAs have expression values different
from that for the remaining mRNAs. An miRNA is
considered to be regulatory if the GST returns a statis-
tically significant p-value.
Another method was proposed by Jayaswal et al. [9]
and is, henceforth, referred to as the odds-ratio (OR)
method. The OR method determines whether there is
an association between miRNA expression and that of
its computationally predicted target mRNAs. If the
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considered to be regulatory. Unlike the GST, the OR
method is based on the expression data from both miR-
NAs and mRNAs. While both methods identify indivi-
dual miRNAs as potentially regulatory, they ignore the
biological observation that a group of miRNAs may co-
regulate a group of mRNAs. Another limitation of the
two methods is that the identification of regulatory miR-
NAs does not provide information about the miRmR
pairs of interest and these pairs have to be identified
separately. Since the experimental validation of an miR-
NA’s regulatory role requires an observable (and statisti-
cally significant) change in the expression of its target
mRNAs, the knowledge of miRmR pairs is essential.
We denote a group of miRNAs and mRNAs as a
module if the miRNAs in a group regulate the mRNAs
i nt h es a m eg r o u p .O n eo ft h ee a r l i e s tm e t h o d sf o rt h e
identification of miRmR modules was proposed by Yoon
and De Micheli [10]. This method is based on computa-
tionally predicted miRmR pairs and does not utilize
miRNA or mRNA expression data. Since miRNAs that
are regulatory in one experimental scenario may not be
regulatory in another, e.g. miRNAs that are regulatory
in breast cancer may not be regulatory in other types of
cancer, this method is of limited use.
Recently, a few integrative methods (i.e. methods that
combine miRNA and mRNA microarray expression data
with miRmR sequence data) have been developed to
obtain miRmR modules. For example, Joung and Fei
[11] used a combination of putative miRmR pairs and
mRNA expression data to identify miRmR modules.
A limitation of their method is that the correlation
between miRNA and mRNA expression data, which
provides statistical evidence for a miRmR pair being reg-
ulatory, is not considered. Joung et al. [12] proposed an
evolutionary algorithm based method for identifying
miRmR modules. While the authors considered correla-
tion among the miRNAs or mRNAs in a module, they
ignored the correlation between miRNAs and mRNAs.
Therefore, their method has the same limitation as
Joung and Fei’s method. Peng et al. [13] proposed a
method based on the correlation between miRNA and
mRNA expression data and this method is, henceforth,
referred to as the Peng-Li method. The authors calcu-
lated the correlation coefficients for all computationally
predicted miRmR pairs followed by the selection of
miRmR pairs that had a statistically significant negative
correlation. Next, the negatively correlated miRmR pairs
were grouped to obtain modules such that each miRNA
in a module targeted all the mRNAs in the module. The
major limitation of the Peng-Li method is that the miR-
NAs and mRNAs in a module are not required to be
enriched (closer than by chance) in terms of their pre-
dicted targets and regulators, respectively. For example,
though miRNAs belonging to the same family are simi-
lar in terms of their target mRNAs (in fact, TargetScanS
predicts the same target mRNAs for all the miRNAs in
a family), the Peng-Li method does not take this into
account while grouping miRNAs. Another limitation is
that the identification of modules is based on a negative
correlation between miRNAs and mRNAs. Since some
recent studies [14] have shown that miRNAs and their
target mRNAs do not always share a negative correla-
tion, a measure of association that incorporates both
directions of change is desirable.
To this end, we propose a novel miRmR module iden-
tification method that has two components - the first
component is the identification of miRNA and mRNA
clusters and the second component is the estimation of
association between the two types of clusters. The
miRNA and mRNA clusters with statistically significant
associations represent the potentially regulatory miRmR
modules. In the next section, we describe our method
and illustrate the method’s ability to identify biologically
meaningful miRmR modules using a matched miRNA
and mRNA microarray data set.
Results
Novel miRmR module identification method
We propose a two-step method (Figure 1) for the identi-
fication of miRmR modules. The first step involves the
identification of miRNA and mRNA clusters that are
enriched in terms of target mRNAs and regulators,
respectively. The mRNA (or miRNA) clusters are
obtained using computationally predicted miRmR pairs
and mRNA (or miRNA) expression data. The second
step involves the identification of miRNA clusters that
have a statistically significant association to one or more
of the mRNA clusters. These associations are obtained
using matched miRNA and mRNA expression data.
Step1: Clustering
The clustering of miRNAs or mRNAs requires two
input parameters - a measure of dissimilarity between
miRNAs or mRNAs and the number of clusters, K.
Once a dissimilarity measure has been obtained, cluster-
ing is performed using the partition around medoids
[15] algorithm. We note that other clustering algo-
rithms, e.g. a hierarchical clustering algorithm [16], can
also be used in our module identification method. In
the rest of this subsection, we focus on the generation
of mRNA clusters and note that a similar approach can
be used for the generation of miRNA clusters. We refer
to a matrix M =( m sw), where 1 ≤ s ≤ Ca n d1≤ w ≤ D,
as a C × D matrix and an element msw of the matrix as
[s, w].
One measure of dissimilarity is the Euclidean distance
between pairs of mRNAs. We obtain this using a
miRmR map matrix of the form Y × X, where Y denotes
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miRNAs. If an miRNA i is predicted to target an mRNA
j, then the element [j, i] of the map matrix takes the
value 1 and 0, otherwise. Henceforth, we refer to the
clustering based on Euclidean distances as unguided
clustering or ClustUN.
The unguided clustering does not take into account
changes in mRNA expression profiles. If only miRmR
pairs are considered, then the Euclidean distance
between an mRNA (say m1)a n dt w oo rm o r ec l u s t e r s
may be identical. Rather than picking one of the clusters
at random, we can use mRNA expression profiles to
(a) 
(b) 
Figure 1 An integrative method for the identification of miRmR modules. (a) Schematic of the module-identification method with key
input parameters and output. (b) Schematic of the multivariate random forest based guided clustering. For a given dissimilarity matrix, the
grouping of miRNAs/mRNAs depends on the number of clusters specified by the user.
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expression profiles closest to m1. Therefore, a measure
of dissimilarity that combines mRNA expression profiles
with predicted miRmR pairs is desirable. Henceforth, we
refer to the clustering based on these pairwise measures
of dissimilarity as guided clustering or ClustGD.
Our guided clustering method (Figure 1b) is based on
multivariate random forest (MRF) [17] and requires two
input matrices - a Y × X miRmR map matrix and a Y ×
T matrix of mRNA expression values, where T denotes
the number of conditions (e.g. the number of time
points or patient categories). In addition to the two
matrices, the following three parameters are required -
(a) Node_size: A node is defined as a collection of
mRNAs and splitting a node results in child nodes. The
child nodes, in turn, are split further till a terminating
condition is reached. The terminating condition is that
the number of mRNAs at a node should be greater than
a user-defined cut-off value. We refer to this cut-off
value as node_size.
(b) Number of trees (N): If splitting a node, say PN,
results in two child nodes, say CN1 and CN2,a n dt h e
number of mRNAs in either of the two child nodes is
less than node_size, then the node PN is not split
further. A node, e.g. PN in the above example, that is
not split is referred to as a terminal node. A binary tree
that is obtained by splitting each node (excluding term-
inal nodes) into exactly two child nodes is referred to as
a regression tree. If T = 1, then the regression tree is
referred to as a univariate regression tree, otherwise it is
referred to as a multivariate regression tree [18,19]. We
denote a collection of multivariate regression trees as a
MRF and N refers to the number of trees in the forest.
(c) Num_cov: For a multivariate regression tree, the
function used to obtain the child nodes is I([j, i] = 1),
where [j, i] is an element of the map matrix Y × X and I
([j, i] = 1) takes the value one if miRNA i targets mRNA
j and the value 0, otherwise. In other words, if a column
i of the Y × X matrix is used to split a node, say BN,
into two child nodes, then all the mRNAs that are tar-
g e t e db ym i R N Aic o n s t i t u t eo n ec h i l dn o d ea n da l lt h e
remaining mRNAs constitute the second child node.
However, there are X different miRNAs and, therefore,
X different ways in which the child nodes, say DN1 and
DN2, can be obtained from BN. Let h denote the
m i R N At h a ti sa c t u a l l yu s e dt os p l i tt h en o d eB Na n d
let xl denote the vector of expression values for the l
th
mRNA. In other words, xl corresponds to the l
th row of
the expression matrix Y × T. Let Qm denote the set of
mRNAs at node θ and xavg denote the vector of average
expression values for the mRNAs in Qm.L e td ( xl, xavg)
denotes the Euclidean distance between the vectors xl
and xavg and let S{ d ( ) } l avg
lQ m
() , θ=
∈ ∑ xx
2
denote a
measure of node homogeneity, i.e. the closeness of
mRNAs in terms of their expression profiles. Let f(BN,
DN1,D N 2)=S ( B N )-S ( D N 1)-S ( D N 2)d e n o t et h e
change in node homogeneity when a node BN is split
into child nodes DN1 and DN2. Since there are X miR-
NAs, we obtain X different values of f(BN, DN1,D N 2)
and h refers to the miRNA that returns the highest
value (see additional file 1: “Supplementary Data” for an
illustration). In practice, owing to time constraint, it is
not feasible to test all the X miRNAs and determine h.
Instead, a randomly chosen subset of the X miRNAs is
used to obtain h. We denote the number of miRNAs in
the subset as num_cov. We typically set num_cov equal
to the square root of the number of miRNAs, as recom-
mended by Xiao and Segal [17].
T h em u l t i v a r i a t er e g r e s s i o nt r e ei su s e dt oo b t a i na
Y × Y matrix, henceforth referred to as the proximity
matrix. Each element of the proximity matrix takes the
value 1 or 0. If two mRNAs, say a and b, belong to the
same terminal node, then [a, b] = 1, else [a, b] = 0.
Though the proximity matrix obtained using a regres-
sion tree has low prediction accuracy, the use of a col-
lection of trees greatly improves the prediction accuracy
[20]. Therefore, we calculate the proximity matrix for
the MRF. If the MRF has N trees, then the element [a,
b] of the MRF proximity matrix is obtained using the
formula [] / a,b N
g
g1
N
= ∑ ,w h e r e[ a ,b ]
g is the value for the
g
th regression tree. While the MRF proximity matrix
(Proxmatrix) measures the similarity between mRNAs,
1 -P r o x matrix, where 1 denotes a Y×Y matrix with every
element equal to 1, measures the dissimilarity between
mRNAs. This dissimilarity matrix is provided as an
input for ClustGD (Figure 1b).
Once the mRNA clusters have been obtained using
ClustUN or ClustGD, we determine the clusters where
the mRNAs are closer to one another than by chance.
Let ES denote the enrichment score and K denote the
total number of clusters. Now, for a given cluster k = 1,
..., K, ES d(o,o )/N km k
ok
=
∈ ∑ . Here, Nk denotes the
number of elements in cluster k, om denotes the median
value of the elements in the k
th cluster and d(o, om)
denotes the Euclidean distance between an element o,
which belongs to cluster k, and om.W en o t et h a toa n d
om are obtained using the relevant rows of the matrix Y
× X. We perform a non-parametric bootstrap test to
determine whether ESk can be obtained by chance.
Firstly, we obtain 100 random clusters of size Nk using
sampling without replacement, i.e. the same mRNA
does not occur more than once in a random cluster.
Secondly, we obtain W1, the number of times the
enrichment score for a random cluster of size Nk is
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cannot be obtained by chance and the k
th cluster is con-
sidered to be statistically significant or enriched.
Let Prenrich denote the percentage of clusters that are
enriched. Therefore, Prenrich =N enrich/Ntotal,w h e r eN en-
rich denotes the number of enriched clusters and Ntotal ≤
K denotes the total number of clusters of size greater
than one. We only consider clusters of size greater than
one because we are interested in mRNAs that are co-
targeted and, hence, co-regulated by a small group of
miRNAs. The Prenrich values are used to compare the
results obtained using ClustUN and ClustGD.T h ec l u s -
tering method that returns a higher value of Prenrich is
used to obtain the mRNA clusters that are provided as
an input to Step 2 of our method.
Step 2: Identification of statistically significant modules
Let Rmir and Rgene denote the number of enriched
miRNA and mRNA clusters, respectively. Now the num-
ber of possible miRmR modules is Rmir ×R gene. For each
module, we obtain the number of miRmR pairs with an
association. A miRmR pair is considered to have an
association if the pair is computationally predicted, i.e.
the Y × X map matrix has the value 1 for the relevant
miRmR pair, and there is evidence of a change in
miRNA expression producing a change in mRNA
expression. To test the latter condition, we assume a lin-
ear model of the form u = a + bv, where u denotes the
change in mRNA expression, v denotes the change in
miRNA expression, a denotes the change in mRNA
expression that is independent of a change in miRNA
expression, and b denotes the change in mRNA expres-
sion due to a unit change in miRNA expression. We
estimate the values of a and b using matched miRNA
and mRNA expression profiles; the expression profiles
correspond to normalized log2 fold-change values with
respect to a reference. Next, we test the null hypothesis
that b = 0 versus the alternate hypothesis that b ≠ 0
using a t-test. If the p-value < 0.05, then there is evi-
dence that a change in miRNA expression produces a
change in mRNA expression.
One advantage of the linear model is that it allows for
c h a n g e si nm i R N Aa n dm R N Ae x p r e s s i o nt ob ei nt h e
same direction or opposite direction. However, with a
slight modification, we can test the one-sided hypothesis
that a change in miRNA expression produces a change
in mRNA expression in the opposite direction. Another
advantage is that it is computationally faster than the
use of correlation coefficient as a measure of association
between a miRmR pair. Typically, the statistical signifi-
cance of correlation coefficient is obtained using a non-
parametric bootstrap test. In contrast, the statistical sig-
nificance of b is determined using a pre-computed table
of significance for t-test.
Let Nm
mir denote the number of miRNAs in the m
th
miRNA cluster and let Nn
gene denote the number of
mRNAs in the n
th mRNA cluster. Let Assoc(m, n)
denote the number of miRmR pairs in the (m, n) mod-
ule with an association. We determine the statistical sig-
nificance of association between the m
th miRNA cluster
and n
th mRNA cluster using a non-parametric bootstrap
test. Firstly, we obtain 100 randomly generated mRNA
clusters of size Nn
gene . Secondly, we obtain Assoc(m, n*),
where n* denotes a randomly generated cluster of size
Nn
gene . Thirdly, we obtain W2, the number of times
Assoc(m, n*) is greater than or equal to Assoc(m, n). If
W2/100 < 0.05, then the association between the m
th
miRNA cluster and n
th mRNA is considered to be sta-
tistically significant. We consider the (m, n) miRmR
module to be potentially regulatory if (i) the association
between the m
th miRNA cluster and n
th mRNA cluster
is statistically significant and (ii) each miRNA in the m
th
cluster targets a majority of mRNAs in the n
th cluster.
In the next subsection, we compare the results
obtained using ClustUN and ClustGD. We tried different
values for node_size and num_cov and obtained the best
Prenrich values for node_size = 5 and num_cov = 15 (see
additional file 1: “Supplementary Data” for an example
of node_size selection). Also, we set N = 100 as a
further increase in the number of trees did not alter the
results.
Guided vs. unguided clustering
We used a publicly available leukemia data set [21] to
compare ClustUN and ClustGD. This data set contained
the mRNA expression profiles of healthy donors and
multiple myeloma (MM) patients belonging to four
categories - no cytogenetic abnormality, cytogenetic
abnormality t(4;14) (with or without RB deletion), cyto-
genetic abnormality t(11;14) (with or without RB dele-
tion), and RB deletion as a unique cytogenetic
abnormality. We identified 3882 differentially expressed
(DE) mRNAs; an mRNA was considered to be DE if the
average expression profile of healthy donors was differ-
ent from that of patients in one or more categories. Of
the 3882 DE mRNAs, we could obtain the plausible
miRmR pairs for only 1492 mRNAs using a combination
of four miRmR target-prediction databases - miRBase
[22], PicTar, TargetScanS and miRGen [23] (intersection
of PicTar(4-way) and TargetScanS). In other words, the
miRmR mapping information was available for only
38.4% of the DE mRNAs. Also, the total number of
miRNAs that targeted one or more of the 1492 DE
mRNAs was 215.
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a 1492 × 215 map matrix such that the rows and col-
umns of the matrix corresponded to mRNAs and miR-
NAs, respectively. An element [j, i] of this matrix took
the value 1 or 0 depending on whether the j
th mRNA
was targeted by the i
th miRNA or not. Next, we
obtained the log2 fold-change values for leukemia
patients with respect to healthy donors and derived the
1492 (mRNA) × 4 (patient categories) expression matrix.
While the map matrix was provided as input to both
ClustUN and ClustGD, the expression matrix was pro-
vided as input to only ClustGD.
Figure 2a shows the Prenrich values for ClustUN and
ClustGD over a range of K values - 40, 50, 60, 70, 80, 90,
and 100. For this range of K values, the average number
of mRNAs per cluster varied from 37.3 to 14.9. Though
the average number of mRNAs per cluster was greater
than one, an individual cluster occasionally had just one
mRNA. A cluster of size one corresponded to an mRNA
that had very few regulators (i.e. miRNAs) in common
with other mRNAs. Since we were interested in identify-
ing clusters of mRNAs that were co-targeted by miR-
N A s ,w ei g n o r e dt h em R N A st h a tb e l o n g e dt oc l u s t e r s
of size one during downstream analysis. For ClustGD,
the total number of clusters of size greater than one was
always equal to K. In contrast, for ClustUN, the number
of clusters of size one increased with an increase in K.
For ClustGD,t h eb e s tP r Enrich value was 80% and it
was obtained for two values of K -50 and 60. For Clus-
tUN,t h eb e s tP r Enrich value was 76.05% and it was
obtained for K = 90. This shows that an iterative
approach, wherein several K values are tried, is required
to obtain the best Prenrich value. Overall, the Prenrich
values for ClustGD were higher than that for ClustUN in
71.4% of the cases.
The mRNA clusters can be obtained using PAM or a
hierarchical clustering algorithm. To compare the results
obtained using the two clustering algorithms, we pro-
vided the output of MRF as an input to an agglomerative
hierarchical clustering algorithm [16]. We varied K from
40 to 100 in increments of 10 and compared the Prenrich
values with those obtained earlier using PAM. The clus-
ters obtained using PAM had a higher Prenrich value for
each value of K (see additional file 1: “Supplementary
Data”).
Identification of miRmR modules
We used a second data set, a timecourse study with
matched miRNA and mRNA microarray expression
profiles, to illustrate our module-identification method.
This data set corresponded to a drug study for MM
patients [9] and had six time points - 0, 2 hrs, 4 hrs,
8 hrs, 24 hrs, and 48 hrs. We identified 9661 DE
mRNAs, i.e. mRNAs for which the changes in expres-
sion profile over the timecourse were statistically sig-
nificant. We could obtain plausible miRmR pairs for
only 3856 (40%) of the DE mRNAs and the total num-
ber of miRNAs that targeted one or more of the 3856
mRNAs was 223. Therefore, for this data set, we
obtained a 3856 × 223 miRmR map matrix and a 3856
(mRNA) × 5 (time points) expression matrix. The
expression matrix had five time points because time
point 0 was used as reference to obtain the log2 fold-
change values.
                                          (a)                                                                                  (b)
Figure 2 Comparison of unguided and guided clustering. The proportion of enriched clusters obtained for (a) leukemia data set and (b)
timecourse data set.
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clusters using ClustUN and ClustGD.W ev a r i e dKf r o m
50 to 140 in intervals of 10 and the average cluster size
varied between 77.1 and 27.5. The PrEnrich values for
ClustGD were higher than or equal to that for ClustUN
in 70% of the cases (Figure 2b). This result was similar
to that obtained for the previous example. While
ClustGD returned clusters of size greater than one for
every value of K, ClustUN returned a few clusters of size
one for K ≥ 130. The best PrEnrich values obtained using
ClustGD and ClustUN were 84% and 78.9%, respectively.
Overall, the highest PrEnrich value was 84% correspond-
ing to K = 50 and these 42 (0.84 × 50) mRNA clusters
were used in Step 2 (Figure 1a) of the module-identifica-
tion method.
In addition to the mRNA clusters, Step 2 requires
miRNA clusters as an input. We obtained 135 DE miR-
NAs and of these DE miRNAs, only 70 were found to
target one or more of the 3856 mRNAs. Therefore, for
miRNA clustering using ClustGD and ClustUN,w eu s e d
the 70 (miRNAs) × 3856 (mRNAs) map matrix and a 70
(miRNAs) × 5 (time points) expression matrix. We
obtained PrEnrich values for K varying between 10 and
30 in intervals of 5. For this range of values, the average
cluster size varied from 7 to 2.3. Both ClustGD and Clus-
tUN returned the same PrEnrich value for K ≥ 20. The
best value of PrEnrich was 88.9% and this was obtained
for several values of K; the smallest of these values was
20. For K = 20, the clusters returned by ClustGD and
ClustUN were similar except for the grouping of miR-21.
This miRNA belonged to a cluster of size one and 41,
respectively, for ClustGD and ClustUN. The miRNA clus-
ters obtained using K = 20 for ClustUN were provided as
input to Step 2 (Figure 1a) of the module-identification
method. We chose ClustUN because it is the simpler of
the two clustering methods and returned the same PrE-
nrich value as that for ClustGD. We obtained 19 miRNA
clusters as potentially regulatory. These included clus-
ters of size one because even a single miRNA can regu-
late multiple mRNAs.
Next, we determined the associations between miRNA
clusters and mRNA clusters. While the linear model
described earlier can be used to obtain positive or nega-
tive associations, we considered only negative associa-
tions because miRNAs act as negative regulators of their
direct targets. For each of the 798 (19 × 42) miRmR
modules, we determined the statistical significance of
association using a non-parametric bootstrap test and
obtained a total of nine potentially regulatory modules
(Figure 3); see additional file 1: “Supplementary Data”
for the list of genes in each module. A potentially regu-
latory miRmR module contained one or more miRNAs.
However, only a small fraction of the mRNAs that were
predicted as targets of these miRNAs was present in the
module (see additional file 1: “Supplementary Data” for
the proportion of predicted target mRNAs present in a
potentially regulatory module). The five miRNA clusters
that had more than one element and belonged to one or
more of the nine potentially regulatory modules were -
(a) miR-135a and miR-135b, (b) miR-148a and miR-
148b, (c) miR-15b, miR-16 and miR-195, (d) miR-30b,
miR-30c and miR-30 d, (e) miR-204 and miR-211 (see
additional file 1: “Supplementary Data” for the expres-
sion profiles of miRNAs in the five modules).
Biological implication and interpretation
To examine the biological significance of the statistically
significant mRNA clusters obtained using ClustGD,w e
performed a gene ontology over-representation analysis
using DAVID [24]. We observed that approximately
12% of the mRNA clusters were enriched for gene
ontology terms (see additional file 1: “Supplementary
Data” for the p-values and a list of mRNAs). Specifically,
the mRNA clusters were enriched for - apoptosis (biolo-
gical process), endomembrane system (cellular compo-
nent), membrane fraction (cellular component),
symporter activity (molecular function), and protein
phosphatase binding (molecular function). In addition,
one of the clusters was enriched for genes in the endo-
cytosis biochemical pathway. In the apoptosis cluster,
RAC1 was a gene of interest as little is known about the
role of RAC1 in myeloma and its progression. RAC1
signalling plays a critical role in apoptosis and tumori-
genesis and has been shown to impair p53-deficient
lymphoma cell growth [25]. Indeed, blockage of RAC1
induces cell cycle arrest or apoptosis in breast cancer
cells [26]. In the biochemical pathway cluster, CXCR4
was a gene of interest. This gene is one of the key mem-
bers of endocytosis biochemical pathway and has been
shown to have clinical significance. Specifically, the
expression of this chemokine receptor, in addition to
CCR1 and CCR2, is correlated with disease state and
survival in myeloma patients [27].
Next, we focused on the potentially regulatory miRmR
modules. The statistically significant miRmR module
containing the miRNAs miR-15b, miR-16, and miR-195
had 84 mRNAs; the miRmR map matrix predicted 81 of
these mRNAs as targets of all three miRNAs. Even
though all the miRmR pairs in this module were not
observed to have a statistically significant association,
grouping these mRNAs and miRNAs together reflects
the predicted regulatory role of the three miRNAs vis-à-
vis the 84 mRNAs.
Although miR-15a was not identified as DE over the
timecourse, miR-15b and miR-15a shared 98% of their
target mRNAs (based on the miRmR map matrix). This
implies that the net effect of a change in the expression
of miR-15a and miR-15b on cellular biology would be
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tified as an oncogenic cluster that is frequently deleted
in chronic lymphocytic leukemia [28]. The clustering of
these two miRNAs suggests that our method is able to
identify biologically relevant miRNA clusters. In addition
to the identification of miR-15 and miR-16 cluster as
important in the pathogenesis of a number of malignan-
cies, the mechanisms explaining their role have also
been described in literature. This cluster has been
shown to modulate multidrug resistance [29], apoptosis
[30-32] and cellular proliferation [32,33]. The role of
this cluster in controlling the proliferation of the cell is
due to the targeting of several key cell-cycle genes such
as Cyclin D1 [34,35] and Cyclin E1 [36]. Furthermore,
miR-195 was identified as belonging to the same cluster
as miR-15b and miR-16, suggesting that miR-195 may
play a role in cell-cycle in a similar manner to miR-15b
and miR-16. This implied function was confirmed in a
study by Xu et al. [37], where ectopic expression of
miR-195 blocked cell cycle progression by regulating Rb-
E2F signaling possibly via an interaction with Cyclin D.
Our analysis may also have the ability to identify other
interactions that were not previously identified, thereby,
providing further information on complex gene regula-
tory pathways. The miRNAs miR-15 and miR-16 induce
apoptosis by suppressing thea n t i - a p o p t o t i cp r o t e i n
BCL-2 [30], and both miRNAs were found to target a
cluster of mRNAs containing among others, G0S2 and
BFAR. G0S2 has previously been shown to interact with
BCL-2 and promote apoptosis by preventing the forma-
tion of BCl-2/Bax heterodimers [38], and BFAR has
been shown to bind to BCL-2 [39].
hsa-let-7c
hsa-miR-128a
hsa-miR-141
mRNA Cluster (115)
<hsa-let-7c: 99.1%>
mRNA Cluster (107)
<hsa-miR-128a: 97.2%>
mRNA Cluster (41)
<hsa-miR-141: 95.1%>
hsa-miR-135a 
hsa-miR-135b
hsa-miR-148a 
hsa-miR-148b
hsa-miR-15b 
hsa-miR-16 
hsa-miR-195
hsa-miR-204 
hsa-miR-211
hsa-miR-30b 
hsa-miR-30c 
hsa-miR-30d
mRNA Cluster (57)
<hsa-miR-135a: 98.2%>
<hsa-miR-135b: 98.2%>
mRNA Cluster (44)
<hsa-miR-148a: 97.7%>
<hsa-miR-148b: 97.7%>
mRNA Cluster (84)
<hsa-miR-15b: 98.8%>
<hsa-miR-16: 97.6%>
<hsa-miR-195: 96.4% >
mRNA Cluster (58)
<hsa-miR-204: 98.3%>
<hsa-miR-211: 94.8%>
mRNA Cluster (123)
<hsa-miR-30b: 98.4%> 
<hsa-miR-30c: 98.4%>
<hsa-miR-30d: 97.6%>
hsa-miR-96 mRNA Cluster (102)
<hsa-miR-96: 85.3%>
Figure 3 Enriched miRmR modules for the timecourse data set. For mRNA clusters, the number of mRNAs is mentioned in brackets. The
notation <: > implies that miRNA  targets % of the mRNAs in the cluster.
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Page 8 of 13Effect of expression data on miRmR modules
For a matched miRNA and mRNA microarray expression
data set, the miRNA and mRNA clusters correspond to
groups of DE miRNAs and mRNAs, respectively, which
are present in the miRmR map matrix. Our timecourse
data set comprised patients with MM and we tested the
null hypothesis that the expression pattern of a biological
entity (miRNA or mRNA) was the same at all time
points. If there was evidence against the null hypothesis,
then we considered the biological entity to be DE. In con-
trast, the MM data set of Gutierrez et al. [21] (described
earlier during the comparison of guided and unguided
clustering methods) comprised healthy individuals and
patients belonging to four categories of cytogenetic
abnormalities. We tested the null hypothesis that the
expression pattern of a biological entity was the same in
all categories of MM patients and in healthy individuals.
If there was evidence against the null hypothesis, then we
considered the biological entity to be DE. Since the null
hypotheses were different for the two data sets, the
resulting DE biological entities (i.e. DE miRNAs and
mRNAs) were different as well. For example, while miR-
15b was DE in the timecourse data set, miR-15a was DE
in the Gutierrez et al. data set.
For the timecourse data set, the number of DE
mRNAs and miRNAs that were present in the miRmR
map matrix was 3856 and 70, respectively. For the
Gutierrez et al. data set, the number of DE mRNAs and
miRNAs that were present in the miRmR map matrix
was 1492 and 168, respectively. Since the DE miRNAs
and mRNAs that were provided as input for clustering
were different for the two data sets, the miRmR modules
obtained using the two data sets were different. For
example, we identified a module comprising miR-30b,
miR-30c, and miR-30 d using the timecourse data set
and a module comprising miR-30a-5p, miR-30b, miR-
30c, miR-30 d, and miR-30e-5p using the Gutierrez
et al. data set (see additional file 1: “Supplementary
Data” for the enriched miRmR modules obtained using
the Gutierrez et al. data set). Similarly, for the time-
course data set, we identified a miRmR module compris-
ing miR-15b, miR-16 and miR-195. In contrast, for the
Gutierrez et al. data set, we identified a miRmR module
comprising miR-15a, miR-16 and miR-195. While the
miRmR module (comprising miR-15, miR-16 and miR-
195) identified using the timecourse data set had
84 mRNAs, the module identified using the Gutierrez
et al. data set had 35 mRNAs. Of these, 16 mRNAs
were common to both modules.
Clustering miRNAs from different families
To determine whether miRNAs from different families
could be grouped together, we modified the miRmR
map matrix so that it contained only one miRNA from
each family. The number of co-targeted mRNAs in the
modified miRmR map matrix was used to determine the
distances between miRNA families. Next, these distances
were used to obtain clusters of miRNA families. For the
timecourse data set, the median number of mRNAs that
were co-targeted by two miRNA families was one. This
implied that the distance between any two miRNA
families was too large for the families to be clustered
together. Indeed, we observed that none of the clusters
with two or more miRNAs were statistically significant.
We generated the miRmR map matrix using a combi-
nation of four target-prediction algorithms - miRanda
(as implemented in miRBase), PicTar, TargetScanS and
miRGen (intersection of PicTar (4-way) and TargetS-
canS). For these algorithms, the number of co-targeted
mRNAs obtained using miRNAs from the same family
was higher than obtained using miRNAs from different
families. Consequently, the miRNA clusters and, hence,
the miRmR modules contained miRNAs from the same
family. It may be possible to obtain miRmR modules
comprising miRNAs from different families using a tar-
get-prediction algorithm such as TargetMiner [40]. To
illustrate this, we reanalyzed the timecourse data set
using a miRmR map matrix based on TargetMiner. The
new miRmR map matrix corresponded to 80 DE miR-
NAs and 4806 DE mRNAs. The value of K, correspond-
ing to the highest Prenrich value, for miRNAs and
mRNAs was 15 and 60, respectively. While the number
of enriched miRNA clusters (including clusters of size
one) was 15, the number of enriched mRNA clusters
was 59. Therefore, the number of possible miRmR mod-
ules was 885 (15 × 59) and nine of these were found to
be statistically significant (see additional file 1: “Supple-
mentary Data” for the enriched miRmR modules
obtained using TargetMiner). We observed that two of
the statistically significant miRmR modules contained
miRNAs from different families - hsa-miR-302b, hsa-
miR-373, and hsa-miR-520e.
Discussion
We present a method for identifying regulatory modules -
miRNA clusters that potentially regulate mRNA clusters.
While some methods, e.g. [10,11] can be used to obtain
miRNA and mRNA clusters without matched miRmR
expression data, our results show that matched expression
data is necessary for identifying the cluster pairs (i.e.
miRmR modules) of potential biological interest. For
example, the miRNAs - miR-15b, miR-16 and miR-195
co-target 341 mRNAs (based on the miRmR map matrix)
and less than 25% of these (84 mRNAs) were included in a
potentially regulatory miRmR module. The remaining co-
targets belonged to other mRNA clusters and were not
found to have a statistically significant association to the
miRNA cluster (miR-15b, miR-16, and miR-195).
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ters that are co-regulated by multiple miRNAs as well as
those that are regulated by just one miRNA. Since the
miRNA clusters are derived from the miRmR map
matrix, miRNAs that share very few co-targets with
other miRNAs belong to clusters of size one. If a
miRNA is not statistically similar (in terms of co-targets)
to other miRNAs, then the associated mRNA cluster is
regulated by just one miRNA. On the other hand, if two
or more miRNAs are statistically similar (in terms
of co-targets), then the associated mRNA cluster is
co-regulated by multiple miRNAs.
Our method can be used to identify miRmR pairs that
have a negative or positive association. A positive asso-
ciation may be indicative of an indirect relationship
between the miRmR pair, e.g. Ritchie et al. [14] showed
a positive association between hsa-miR-92 and PCNA.
Therefore, our method can be used to obtain miRmR
modules that represent either direct regulation or indir-
ect regulation of mRNAs. The current measure of asso-
ciation can also be extended to capture other desired
and more complex relationships. For example, in case of
t i m e c o u r s ed a t a ,t h e r em a yb eat i m el a gb e t w e e n
changes in miRNA expression and that of its target
mRNAs. Since the output of our method is a network of
interactions between miRNAs and mRNAs, capturing
the time-lag information can enable the identification of
variations in modules over time. These time-dependent
modules could perhaps be used as an initial step in the
construction of gene regulatory networks.
A potentially regulatory miRmR module has a statisti-
cally significant association between the miRNA cluster
and mRNA cluster. However, every miRmR pair in the
module is not required to have a statistically significant
association. This may enable us to identify relationships
that were hitherto hidden owing to the noise in expres-
sion data. The module comprising 84 mRNAs and three
miRNAs (miR-15b, miR-16 and miR-195) had mRNAs
(e.g. G0S2 and BFAR) with a statistically significant
negative association to all three miRNAs. In contrast,
some mRNAs (WDTC1, PEX13, FAM54B, and
PPP1R11) had a statistically significant negative associa-
tion to only miR-195. Since these associations were
obtained using a short timecourse data set (five time
points), which has the problem of noise, we recommend
that all three miRNAs be considered as co-regulators of
the four mRNAs. Unlike our method, the Peng-Li
method requires every miRmR pair in a module to have
a statistically significant association. Therefore, the
Peng-Li method would split the 84 mRNAs into several
modules, e.g. the four mRNAs that had a negative asso-
ciation to only miR-195 would form one module. In this
regard, the Peng-Li method can be treated as a special
case of our method.
We note that the miRmR modules will vary based on
the input miRmR map matrix. For the timecourse data
set, the miRmR modules obtained using a combination
of miRanda, PicTar, TargetScanS and miRGen were dif-
ferent from that obtained using TargetMiner. For a
miRmR module containing multiple miRNAs, all the
miRNAs could be from the same family. This is because
the miRNAs from the same family share multiple targets
in the map matrix. It is possible to change the map
matrix and consider miRNA families instead of indivi-
dual miRNAs. This would ensure that a miRmR module
with multiple miRNAs contains miRNAs from different
families. However, such a map matrix should be consid-
ered only if the miRNAs in a family have similar expres-
sion profiles. Otherwise, the association between
individual miRNAs in the family and mRNA would vary,
resulting in a weak (and perhaps not statistically signifi-
cant) overall association between the miRNA family and
mRNA. This, in turn, would reduce the number of
enriched miRmR modules.
Conclusions
We present a miRmR module identification method that
facilitates better biological interpretation of high-
throughput miRNA and mRNA microarray data. A typi-
cal analysis of microarray data returns numerous
mRNAs (> 1000) and miRNAs (> 100) as DE. Since
each DE miRNA potentially targets hundreds of DE
mRNAs, the number of potential miRmR interactions
exceeds 1,00,000. Our method converts this massive
amount of information into a small number of poten-
tially regulatory miRmR modules, thereby, enabling biol-
ogists to identify the miRNAs and mRNAs for further
experimentation. For example, for the timecourse data
set, our method reduced the number of potential
miRmR interactions from over 1,00,000 to just nine
miRmR modules.
Methods
Preprocessing of “leukemia data set”
We obtained a publicly available data set, GSE16558
[21], from the Gene Expression Omnibus [41,42] reposi-
tory. This data set corresponds to a MM study compris-
ing healthy donors and patients belonging to four
categories - no cytogenetic abnormality, cytogenetic
abnormality t(4;14) (with or without RB deletion), cyto-
genetic abnormality t(11;14) (with or without RB dele-
tion), and RB deletion as a unique cytogenetic
abnormality. The miRNA expression profiles were
obtained using TaqMan low-density arrays. These
expression profiles were normalized using the mean of
RNU44 and RNU48, as suggested by the authors [21].
The mRNA expression profiles were obtained using
Affymetrix Human Gene 1.0 ST arrays and the
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tion [43], quantile normalization [44] and summariza-
tion of mRNA expression using the median polish
algorithm.
After normalization, we obtained the log2 fold-change
values for MM patients with respect to healthy donors.
For each Affymetrix probeset, we tested the null hypoth-
esis that there was no difference in log2 fold-change
values over the four patient categories. Next, we
adjusted the p-values for multiple comparisons using
the Benjamini and Hochberg (BH) [45] method and
obtained DE probesets, i.e. probesets with adjusted
p-values less than 0.05. Since one or more probesets
map to the same mRNA, we considered an mRNA to be
DE if at least one of the associated probesets was DE.
Similarly, we obtained the DE miRNAs.
Preprocessing of “timecourse data set”
We considered a short timecourse data set comprising
matched miRNA and mRNA microarray expression
data. This data set corresponded to a drug study invol-
ving MM patients [9] and had six time points - 0, 2 hrs,
4 hrs, 8 hrs, 24 hrs, and 48 hrs. The miRNA expression
data was obtained using Exiqon arrays (V 8.1) and the
mRNA expression data was obtained using Affymetrix
arrays (Human Genome U133 Plus 2.0 array). For the
two-color miRNA data, data preprocessing steps
included background intensity subtraction and within-
array-normalization [46] using the global loess method.
For the single-color mRNA data, data preprocessing
steps included RMA background correction [43], quan-
tile normalization [44] and summarization of mRNA
expression using the median polish algorithm. We note
that each miRNA corresponded to two probes on an
Exiqon array and each mRNA corresponded to one or
more probesets on the Affymetrix array. Henceforth, we
use the terms probe and probeset interchangeably.
For each probeset, we tested the null hypothesis that
there was no difference in expression profiles over the
timecourse. The p-values were adjusted for multiple
comparisons using the BH [45] method. We considered
a probeset to be DE if the adjusted p-value was less
than 0.05. Since one or more probesets map to the
same miRNA or mRNA, we considered an miRNA or
mRNA to be DE if at least one of the associated probe-
sets was DE.
Generation of miRNA-mRNA map matrix
We obtained the plausible miRmR pairs by combining
the results from four target-prediction databases - miR-
Base, PicTar, TargetScanS and miRGen (intersection of
PicTar(4-way) and TargetScanS). Specifically, we consid-
ered a miRmR pair to be plausible if it was predicted by
at least two of the four databases. Therefore, an element
[j, i] of the miRmR map matrix took the value 1 if the
j
th mRNA was predicted as a target of the i
th miRNA by
two or more target-prediction databases. Otherwise, the
element [j, i] took the value 0.
Generation of expression matrix for clustering
Since each miRNA or mRNA corresponded to one or
more probesets, the median of the log2 fold-change values
over the relevant probesets was considered to be the log2
fold-change value for the miRNA or mRNA of interest. If
there were T conditions, e.g. T time points, then the med-
ian log2 fold-change value was calculated for each condi-
tion and a Z × T expression matrix obtained, where Z
denotes the number of miRNAs or mRNAs.
Additional material
Additional file 1: Supplementary Data. This file contains (1) a simple
illustration of the MRF method, (2) enrichment scores for different values
of node_size, (3) a comparison of PAM and hierarchical clustering
algorithms, (4) mRNA clusters enriched for GO terms, (5) p-values for
potentially regulatory miRmR modules, (6) list of miRNAs and mRNAs in
statistically significant miRmR modules, (7) expression profiles of miRNAs
in statistically significant miRmR modules, (8) proportion of predicted
target mRNAs in a potentially regulatory module, (9) enriched miRmR
modules for the Gutierrez et al. data set, and (10) enriched miRmR
modules for the timecourse data set obtained using TargetMiner.
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